BrainStorm Cell Therapeutics
BCLI
#10372
Rank
โ‚น0.62 B
Marketcap
โ‚น56.34
Share price
-7.46%
Change (1 day)
-59.82%
Change (1 year)

Revenue for BrainStorm Cell Therapeutics (BCLI)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BrainStorm Cell Therapeutics from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
โ‚น914.68 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.643 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น209.03 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚น7.92 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น9.70 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚น10.24 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA